stemline therapeutics inc
(STML:Consolidated Issue listed on NASDAQ Capital Market)
Eric K. Rowinsky M.D.
Chief Medical Officer, Head of Research & Development and Executive Vice President, Stemline Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 92 board members in 9 different organizations across 17 different industries.|
See Board Relationships
As of Fiscal Year 2013
Dr. Eric K. Rowinsky, M.D. has been the Chief Medical Officer, Head of Research & Development and Executive Vice President at Stemline Therapeutics, Inc., since November 2011. Dr. Rowinsky has been a Consultant at Coronado Biosciences, Inc., since October 2010. He serves as Consultant/Scientific Advisor to multiple biotech and pharmaceutical companies in cancer drug development. He has been an Independent Consultant since January 2010. He has been Strategic Advisor for ...
750 Lexington AvenuePhone: 646-502-2311
New York, New York 10022
Board Members Memberships*
Former Director and Member of Oncology Scientific Advisory Board
Former Director and Member of Special Committee
Independent Director, Member of Compensation & Management Development Committee, Member of Science & Technology Committee and Member of Corporate Governance Committee
Chairman of the Scientific Advisory Board and Director
Vice Chairman, Consultant and Member of Strategic Transaction Committee
Director and Member of Nominating & Corporate Governance Committee
New York University
School of Medicine, Vanderbilt University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|There is no Competitor Compensation data available.|